WAM
CVS icon

Wallington Asset Management’s CVS Health CVS Stock Holding History

Wallington Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-113,900
Closed -$7.16M – 95
2024
Q3 		$7.16M Sell
113,900
-2,575
-2% -$150K 1% 34
2024
Q2 		$6.88M Sell
116,475
-5,810
-5% -$363K 1.05% 33
2024
Q1 		$9.75M Buy
122,285
+319
+0.3% +$24.4K 1.53% 30
2023
Q4 		$9.63M Buy
121,966
+1,320
+1% +$93.9K 1.62% 28
2023
Q3 		$8.42M Buy
120,646
+1,155
+1% +$81.8K 1.53% 31
2023
Q2 		$8.26M Buy
119,491
+303
+0.3% +$21.6K 1.48% 32
2023
Q1 		$8.86M Buy
119,188
+530
+0.4% +$44.4K 1.77% 25
2022
Q4 		$11.1M Buy
118,658
+877
+0.7% +$84.6K 2.39% 19
2022
Q3 		$11.2M Buy
117,781
+703
+0.6% +$69.6K 2.66% 16
2022
Q2 		$10.8M Buy
117,078
+405
+0.3% +$39.5K 2.2% 18
2022
Q1 		$11.8M Buy
116,673
+1,230
+1% +$129K 2.04% 23
2021
Q4 		$11.9M Sell
115,443
-300
-0.3% -$27.7K 1.82% 25
2021
Q3 		$9.82M Sell
115,743
-298
-0.3% -$25K 1.63% 29
2021
Q2 		$9.68M Buy
116,041
+1,804
+2% +$148K 1.66% 26
2021
Q1 		$8.59M Sell
114,237
-227
-0.2% -$16.5K 1.56% 29
2020
Q4 		$7.82M Buy
114,464
+855
+0.8% +$55.6K 1.53% 27
2020
Q3 		$6.63M Buy
113,609
+350
+0.3% +$21.8K 1.54% 26
2020
Q2 		$7.36M Sell
113,259
-70
-0.1% -$4.41K 1.82% 25
2020
Q1 		$6.72M Buy
113,329
+503
+0.4% +$33.6K 1.86% 24
2019
Q4 		$8.38M Buy
112,826
+490
+0.4% +$34.4K 1.78% 25
2019
Q3 		$7.08M Buy
112,336
+766
+0.7% +$45.4K 1.72% 23
2019
Q2 		$6.08M Buy
111,570
+1,220
+1% +$65.7K 1.5% 29
2019
Q1 		$5.95M Sell
110,350
-600
-0.5% -$37K 1.56% 30
2018
Q4 		$7.27M Sell
110,950
-313
-0.3% -$23.4K 2.18% 20
2018
Q3 		$8.76M Sell
111,263
-670
-0.6% -$47.9K 2.09% 22
2018
Q2 		$7.2M Buy
111,933
+250
+0.2% +$16.5K 1.84% 25
2018
Q1 		$6.95M Sell
111,683
-3,050
-3% -$219K 1.84% 25
2017
Q4 		$8.32M Sell
114,733
-1,855
-2% -$135K 2.14% 20
2017
Q3 		$9.48M Sell
116,588
-1,040
-0.9% -$82.3K 2.52% 14
2017
Q2 		$9.46M Sell
117,628
-705
-0.6% -$55.7K 2.63% 12
2017
Q1 		$9.29M Sell
118,333
-260
-0.2% -$20.8K 2.64% 15
2016
Q4 		$9.36M Sell
118,593
-1,649
-1% -$133K 2.9% 10
2016
Q3 		$10.7M Sell
120,242
-1,849
-2% -$175K 3.52% 7
2016
Q2 		$11.7M Buy
122,091
+370
+0.3% +$36.9K 3.65% 5
2016
Q1 		$12.6M Buy
121,721
+1,543
+1% +$150K 4.13% 4
2015
Q4 		$11.8M Buy
120,178
+10
+0% +$979 4.04% 5
2015
Q3 		$11.6M Buy
120,168
+1,150
+1% +$121K 4.17% 2
2015
Q2 		$12.5M Sell
119,018
-20,233
-15% -$2.07M 4% 2
2015
Q1 		$14.4M Buy
139,251
+1,155
+0.8% +$117K 4.49% 2
2014
Q4 		$13.3M Sell
138,096
-2,797
-2% -$246K 4.26% 1
2014
Q3 		$11.2M Sell
140,893
-986
-0.7% -$77.7K 3.79% 3
2014
Q2 		$10.7M Buy
141,879
+1,005
+0.7% +$76K 3.65% 4
2014
Q1 		$10.5M Sell
140,874
-1,380
-1% -$97.5K 3.71% 4
2013
Q4 		$10.2M Buy
142,254
+2,298
+2% +$148K 3.72% 4
2013
Q3 		$7.94M Buy
139,956
+2,370
+2% +$141K 3.27% 6
2013
Q2 		$7.87M Buy
+137,586
New +$7.97M 3.34% 6

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wallington Asset Management's CVS Position: Q4 2024 in Review

Wallington Asset Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 113,900 shares — an estimated $7.16M sold.

Wallington Asset Management first reported a position in CVS in Q2 2013 and held it in 46 quarters. The position peaked at $14.4M in Q1 2015. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Wallington Asset Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Wallington Asset Management sold 113,900 CVS Health shares in Q4 2024, an estimated $7.16M.
  • Wallington Asset Management first reported a position in CVS Health in Q2 2013 and held it in 46 quarters.
  • Wallington Asset Management's CVS Health position peaked at $14.4M in Q1 2015.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Wallington Asset Management's 13F filing for Q4 2024, filed 15 Jan 2025.